Mizuho upgraded shares of Chemours (NYSE:CC – Free Report) from a neutral rating to an outperform rating in a report released on Thursday morning, MarketBeat.com reports. They currently have $19.00 price objective on the specialty chemicals company’s stock.
CC has been the subject of a number of other research reports. Morgan Stanley dropped their price target on Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. Truist Financial assumed coverage on shares of Chemours in a report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price target for the company. Barclays decreased their price objective on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Monday, February 24th. Royal Bank of Canada restated an “outperform” rating and set a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. Finally, BMO Capital Markets decreased their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $22.89.
Read Our Latest Research Report on CC
Chemours Stock Down 4.0 %
Chemours (NYSE:CC – Get Free Report) last posted its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. Equities research analysts forecast that Chemours will post 2.03 EPS for the current year.
Chemours Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.29%. The ex-dividend date of this dividend was Friday, February 28th. Chemours’s payout ratio is 175.44%.
Institutional Trading of Chemours
Several hedge funds and other institutional investors have recently made changes to their positions in the company. GAMMA Investing LLC boosted its position in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 765 shares during the period. Truvestments Capital LLC bought a new position in shares of Chemours during the third quarter valued at $35,000. Brooklyn Investment Group acquired a new position in shares of Chemours during the third quarter worth $37,000. Quadrant Capital Group LLC grew its stake in shares of Chemours by 100.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 1,119 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Chemours in the fourth quarter worth $48,000. 76.26% of the stock is currently owned by institutional investors.
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Featured Stories
- Five stocks we like better than Chemours
- What is the Nasdaq? Complete Overview with History
- MarketBeat Week in Review – 03/24 – 03/28
- What is MarketRank™? How to Use it
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Dividend Payout Ratio Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.